tiprankstipranks
Advertisement
Advertisement

BIIB Stock Latest News

Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data
Company AnnouncementsBiogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data
2d ago
BIIB
Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab
PremiumWeekend Updates
Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab
5d ago
GD
TMO
Biogen completes acquisition of RayThera
PremiumThe Fly
Biogen completes acquisition of RayThera
7d ago
BIIB
Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story
PremiumCompany Announcements
Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story
7d ago
BIIB
Biogen price target raised to $241 from $221 at Mizuho
PremiumThe Fly
Biogen price target raised to $241 from $221 at Mizuho
9d ago
BIIB
Biogen price target raised to $215 from $200 at Citi
PremiumThe FlyBiogen price target raised to $215 from $200 at Citi
10d ago
BIIB
Biogen price target raised to $231 from $222 at Morgan Stanley
Premium
The Fly
Biogen price target raised to $231 from $222 at Morgan Stanley
14d ago
BIIB
Biogen price target raised to $251 from $237 at H.C. Wainwright
Premium
The Fly
Biogen price target raised to $251 from $237 at H.C. Wainwright
14d ago
BIIB
Biogen price target lowered to $240 from $242 at RBC Capital
PremiumThe Fly
Biogen price target lowered to $240 from $242 at RBC Capital
14d ago
BIIB
Biogen price target raised to $240 from $225 at UBS
PremiumThe Fly
Biogen price target raised to $240 from $225 at UBS
14d ago
BIIB
Biogen price target raised to $215 from $201 at Wedbush
PremiumThe Fly
Biogen price target raised to $215 from $201 at Wedbush
14d ago
BIIB
Biogen price target raised to $219 from $215 at BofA
PremiumThe Fly
Biogen price target raised to $219 from $215 at BofA
14d ago
BIIB
Biogen price target raised to $225 from $215 at TD Cowen
PremiumThe FlyBiogen price target raised to $225 from $215 at TD Cowen
14d ago
BIIB
Biogen price target raised to $248 from $245 at Canaccord
Premium
The Fly
Biogen price target raised to $248 from $245 at Canaccord
14d ago
BIIB
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
Premium
Company Announcements
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
15d ago
BIIB
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
PremiumRatings
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
15d ago
BIIB
Morning Movers: Generac, Amphenol climb following earnings
PremiumThe Fly
Morning Movers: Generac, Amphenol climb following earnings
15d ago
F
V
Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25
PremiumThe Fly
Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25
15d ago
BIIB
Biogen reports Q2 EPS $3.60, consensus $2.05
PremiumThe Fly
Biogen reports Q2 EPS $3.60, consensus $2.05
15d ago
BIIB
Biogen price target raised to $200 from $185 at Barclays
PremiumThe FlyBiogen price target raised to $200 from $185 at Barclays
15d ago
BIIB
Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors
Premium
Company Announcements
Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors
17d ago
BIIB
BIIB Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BIIB Upcoming Earnings Report: What to Expect?
17d ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >